MyFinsight
Home
Blog
About
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1255.81%
Quick Ratio
1255.81%
Cash Ratio
1052.84%
Debt to Asset Ratio
25.39%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Short-term marketable debt secur...
Other receivables
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Long-term debt
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
477,905
298,490
334,517
350,736
Short-term marketable debt securities
59,125
59,431
59,451
29,743
Prepaid expenses
26,447
32,957
22,857
26,714
Other receivables
6,561
5,763
4,869
4,022
Total current assets
570,038
396,641
421,694
411,215
Operating lease right-of-use assets
2,078
1,857
1,566
1,911
Property and equipment, net
487
532
577
622
Other non-current assets
1,344
1,344
596
587
Total non-current assets
3,909
3,733
2,739
3,120
Total assets
573,947
400,374
424,433
414,335
Trade and other payables
17,038
23,380
29,553
25,282
Accrued expenses and other current liabilities
27,108
21,814
14,691
21,587
Short-term portion of operating lease liabilities
1,246
920
1,234
1,499
Total current liabilities
45,392
46,114
45,478
48,368
Long-term debt
99,514
99,018
74,100
73,741
Long-term portion of operating lease liabilities
772
865
374
486
Pension liability
74
353
0
549
Total non-current liabilities
100,360
100,236
74,474
74,776
Total liabilities
145,752
146,350
119,952
123,144
Common shares
8
7
7
6
Common shares-Common Class C
-
-
0
0
Additional paid-in capital
1,021,980
786,313
766,781
689,108
Accumulated deficit
-594,423
-532,618
-462,911
-400,486
Accumulated other comprehensive income
630
322
604
278
Total shareholders equity
428,195
254,024
304,481
288,906
Noncontrolling interests
-
-
0
2,285
Total equity
-
-
304,481
291,191
Total liabilities and shareholders' equity
573,947
400,374
424,433
414,335
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$477,905K
(55.83%↑ Y/Y)
Short-term marketable debt
securities
$59,125K
(-50.06%↓ Y/Y)
Prepaid expenses
$26,447K
(-2.01%↓ Y/Y)
Other receivables
$6,561K
(92.46%↑ Y/Y)
Operating lease
right-of-use assets
$2,078K
(-7.69%↓ Y/Y)
Other non-current
assets
$1,344K
(-20.80%↓ Y/Y)
Property and equipment,
net
$487K
(-26.99%↓ Y/Y)
Total current assets
$570,038K
(25.15%↑ Y/Y)
Total non-current
assets
$3,909K
(-15.30%↓ Y/Y)
Total assets
$573,947K
(24.75%↑ Y/Y)
Total liabilities and
shareholders' equity
$573,947K
(24.75%↑ Y/Y)
Total shareholders
equity
$428,195K
(21.05%↑ Y/Y)
Total liabilities
$145,752K
(42.68%↑ Y/Y)
Accumulated deficit
-$594,423K
(-79.72%↓ Y/Y)
Additional paid-in capital
$1,021,980K
(49.42%↑ Y/Y)
Total non-current
liabilities
$100,360K
(34.19%↑ Y/Y)
Total current
liabilities
$45,392K
(65.90%↑ Y/Y)
Accumulated other
comprehensive income
$630K
(21.15%↑ Y/Y)
Common shares
$8K
(33.33%↑ Y/Y)
Long-term debt
$99,514K
(35.61%↑ Y/Y)
Long-term portion of
operating lease...
$772K
(-7.66%↓ Y/Y)
Pension liability
$74K
(-87.11%↓ Y/Y)
Accrued expenses and
other current...
$27,108K
(210.44%↑ Y/Y)
Trade and other
payables
$17,038K
(-0.24%↓ Y/Y)
Short-term portion of
operating lease...
$1,246K
(-19.61%↓ Y/Y)
Buy us a coffee